https://www.pearceip.law/2026/09/16/new-formulations-of-alvotech-fuji-pharmas-golimumab-ustekinumab-biosimilars-approved-in-japan/
New Formulations of Alvotech/Fuji Pharma’s Golimumab & Ustekinumab Biosimilars Approved in Japan |...
Sep 29, 2026 - On 16 September 2026, Fuji Pharma announced that it has obtained marketing approval in Japan for Golimumab BS 50 mg autoinjector for subcutaneous injection...
new formulationsin japanalvotechfujigolimumab
https://www.croiwebcasts.org/p/2017croi/croi33375
CROI Webcasts: NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
croiwebcastsnewhivdrugs